| Stem definition | Drug id | CAS RN |
|---|---|---|
| vinca alkaloids | 3644 | 162652-95-1 |
None
None
None
None
None
None
None
| Source | Code | Description |
|---|---|---|
| ATC | L01CA05 | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS ANTINEOPLASTIC AGENTS PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS Vinca alkaloids and analogues |
| CHEBI has role | CHEBI:35610 | antineoplastic agents |
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Transitional cell carcinoma | indication | 27090000 | DOID:2671 |
None
None
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 11.32 | acidic |
| pKa2 | 13.35 | acidic |
| pKa3 | 7.39 | Basic |
| pKa4 | 6.11 | Basic |
| pKa5 | 5.01 | Basic |
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Tubulin beta | Tumour-associated antigen | INHIBITOR | SCIENTIFIC LITERATURE | SCIENTIFIC LITERATURE |
| ID | Source |
|---|---|
| D09032 | KEGG_DRUG |
| 194468-36-5 | SECONDARY_CAS_RN |
| C0672663 | UMLSCUI |
| CHEBI:90241 | CHEBI |
| CHEMBL2110725 | ChEMBL_ID |
| CHEMBL2105629 | ChEMBL_ID |
| DB11641 | DRUGBANK_ID |
| C111217 | MESH_SUPPLEMENTAL_RECORD_UI |
| 7499 | INN_ID |
| 5BF646324K | UNII |
| 10629256 | PUBCHEM_CID |
| 013377 | NDDF |
| 013378 | NDDF |
| 698843001 | SNOMEDCT_US |
None